Literature DB >> 22545673

Testing an aflatoxin B1 gene signature in rat archival tissues.

B Alex Merrick1, Scott S Auerbach, Patricia S Stockton, Julie F Foley, David E Malarkey, Robert C Sills, Richard D Irwin, Raymond R Tice.   

Abstract

Archival tissues from laboratory studies represent a unique opportunity to explore the relationship between genomic changes and agent-induced disease. In this study, we evaluated the applicability of qPCR for detecting genomic changes in formalin-fixed, paraffin-embedded (FFPE) tissues by determining if a subset of 14 genes from a 90-gene signature derived from microarray data and associated with eventual tumor development could be detected in archival liver, kidney, and lung of rats exposed to aflatoxin B1 (AFB1) for 90 days in feed at 1 ppm. These tissues originated from the same rats used in the microarray study. The 14 genes evaluated were Adam8, Cdh13, Ddit4l, Mybl2, Akr7a3, Akr7a2, Fhit, Wwox, Abcb1b, Abcc3, Cxcl1, Gsta5, Grin2c, and the C8orf46 homologue. The qPCR FFPE liver results were compared to the original liver microarray data and to qPCR results using RNA from fresh frozen liver. Archival liver paraffin blocks yielded 30 to 50 μg of degraded RNA that ranged in size from 0.1 to 4 kB. qPCR results from FFPE and fresh frozen liver samples were positively correlated (p ≤ 0.05) by regression analysis and showed good agreement in direction and proportion of change with microarray data for 11 of 14 genes. All 14 transcripts could be amplified from FFPE kidney RNA except the glutamate receptor gene Grin2c; however, only Abcb1b was significantly upregulated from control. Abundant constitutive transcripts, S18 and β-actin, could be amplified from lung FFPE samples, but the narrow RNA size range (25-500 bp length) prevented consistent detection of target transcripts. Overall, a discrete gene signature derived from prior transcript profiling and representing cell cycle progression, DNA damage response, and xenosensor and detoxication pathways was successfully applied to archival liver and kidney by qPCR and indicated that gene expression changes in response to subchronic AFB1 exposure occurred predominantly in the liver, the primary target for AFB1-induced tumors. We conclude that an evaluation of gene signatures in archival tissues can be an important toxicological tool for evaluating critical molecular events associated with chemical exposures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22545673      PMCID: PMC3358548          DOI: 10.1021/tx3000945

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  60 in total

1.  Super-induced gene expression of the N-methyl-D-aspartate receptor 2C subunit in chemical-induced hypertrophic liver in rats.

Authors:  Kiyomitsu Nemoto; Takahiro Tanaka; Ayaka Ikeda; Sei Ito; Masanori Mizukami; Tokihiro Hikida; Toshie Gamou; Wataru Habano; Shogo Ozawa; Kaoru Inoue; Midori Yoshida; Akiyoshi Nishikawa; Masakuni Degawa
Journal:  J Toxicol Sci       Date:  2011-10       Impact factor: 2.196

2.  Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens.

Authors:  Mari Iida; Colleen H Anna; Wanda M Holliday; Jennifer B Collins; Michael L Cunningham; Robert C Sills; Theodora R Devereux
Journal:  Carcinogenesis       Date:  2004-12-23       Impact factor: 4.944

3.  Carcinogenesis in rats by aflatoxins B1, G1, and B2.

Authors:  W H Butler; M Greenblatt; W Lijinsky
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

4.  Prognostic gene expression signature for squamous cell carcinoma of lung.

Authors:  Chang-Qi Zhu; Dan Strumpf; Chun-Yan Li; Qing Li; Ni Liu; Sandy Der; Frances A Shepherd; Ming-Sound Tsao; Igor Jurisica
Journal:  Clin Cancer Res       Date:  2010-08-25       Impact factor: 12.531

5.  Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques.

Authors:  Gulisa Turashvili; Winnie Yang; Steven McKinney; Steve Kalloger; Nadia Gale; Ying Ng; Katie Chow; Lynda Bell; Julie Lorette; Melinda Carrier; Margaret Luk; Samuel Aparicio; David Huntsman; Stephen Yip
Journal:  Exp Mol Pathol       Date:  2011-09-21       Impact factor: 3.362

6.  Gene expression analysis using long-term preserved formalin-fixed and paraffin-embedded tissue of non-small cell lung cancer.

Authors:  Therese A S Jacobson; Joachim Lundahl; Håkan Mellstedt; Ali Moshfegh
Journal:  Int J Oncol       Date:  2011-02-08       Impact factor: 5.650

7.  Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples.

Authors:  Marshall S Scicchitano; Deidre A Dalmas; Melissa A Bertiaux; Shawn M Anderson; Leah R Turner; Roberta A Thomas; Rossana Mirable; Rogely W Boyce
Journal:  J Histochem Cytochem       Date:  2006-07-24       Impact factor: 2.479

8.  Predicting the hepatocarcinogenic potential of alkenylbenzene flavoring agents using toxicogenomics and machine learning.

Authors:  Scott S Auerbach; Ruchir R Shah; Deepak Mav; Cynthia S Smith; Nigel J Walker; Molly K Vallant; Gary A Boorman; Richard D Irwin
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-11       Impact factor: 4.219

9.  Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma.

Authors:  Philippe Riou; Raphael Saffroy; Catherine Chenailler; Brigitte Franc; Carla Gentile; Eric Rubinstein; Therese Resink; Brigitte Debuire; Dominique Piatier-Tonneau; Antoinette Lemoine
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

10.  Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma.

Authors:  Naomi Walsh; Annemarie Larkin; Susan Kennedy; Lisa Connolly; Jo Ballot; Wei Ooi; Giuseppe Gullo; John Crown; Martin Clynes; Lorraine O'Driscoll
Journal:  BMC Urol       Date:  2009-06-24       Impact factor: 2.264

View more
  7 in total

1.  Hepatic transcriptomic alterations for N,N-dimethyl-p-toluidine (DMPT) and p-toluidine after 5-day exposure in rats.

Authors:  June K Dunnick; Keith R Shockley; Daniel L Morgan; Amy Brix; Gregory S Travlos; Kevin Gerrish; J Michael Sanders; T V Ton; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2016-09-16       Impact factor: 5.153

2.  Molecular Changes in the Nasal Cavity after N, N-dimethyl-p-toluidine Exposure.

Authors:  June K Dunnick; B Alex Merrick; Amy Brix; Daniel L Morgan; Kevin Gerrish; Yu Wang; Gordon Flake; Julie Foley; Keith R Shockley
Journal:  Toxicol Pathol       Date:  2016-04-20       Impact factor: 1.902

3.  Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.

Authors:  Natalie M Johnson; Patricia A Egner; Victoria K Baxter; Michael B Sporn; Ryan S Wible; Thomas R Sutter; John D Groopman; Thomas W Kensler; Bill D Roebuck
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-24

4.  Generation of a New Model Rat: Nrf2 Knockout Rats Are Sensitive to Aflatoxin B1 Toxicity.

Authors:  Keiko Taguchi; Misaki Takaku; Patricia A Egner; Masanobu Morita; Takehito Kaneko; Tomoji Mashimo; Thomas W Kensler; Masayuki Yamamoto
Journal:  Toxicol Sci       Date:  2016-04-12       Impact factor: 4.849

5.  Ruminal Transcriptomic Analysis of Grass-Fed and Grain-Fed Angus Beef Cattle.

Authors:  Yaokun Li; José A Carrillo; Yi Ding; YangHua He; Chunping Zhao; Linsen Zan; Jiuzhou Song
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

6.  RNA-Seq profiling reveals novel hepatic gene expression pattern in aflatoxin B1 treated rats.

Authors:  B Alex Merrick; Dhiral P Phadke; Scott S Auerbach; Deepak Mav; Suzy M Stiegelmeyer; Ruchir R Shah; Raymond R Tice
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

Review 7.  Improving the human hazard characterization of chemicals: a Tox21 update.

Authors:  Raymond R Tice; Christopher P Austin; Robert J Kavlock; John R Bucher
Journal:  Environ Health Perspect       Date:  2013-04-19       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.